The document compares the venture capital industry to the drug trade. It outlines the major players in the industry as suppliers of capital (endowments, pensions, family offices), venture capital firms that lead investments, and startups. It notes that venture capital makes up a small portion of overall institutional investment portfolios. Lead investors help companies with strategy, due diligence, and take board seats, while co-investors do not provide as much support. Investors only invest in deals that fit their existing investment thesis at an acceptable valuation and size.